
The 2026 Psychiatric Pharmacotherapy Update offers 14+ hours of high-level, evidence-based continuing education (CPE, CME, CNE, APA, and Social Work). This interprofessional seminar focuses on "Serious Science," providing clinicians with the most rigorous and timely data to improve the quality of care for patients with mental health disorders.Date: Oct 22, 2026 08:00 AM - Oct 23, 2026 05:00 AM
Registration closes on Oct 24, 2026 12:00 AM
Welcome to a premier interprofessional gathering of mental health leaders! We are thrilled to have you join us for a dedicated exploration of advanced psychiatric pharmacotherapy.
This year we are adding FREE addtional BONUS CE webinars. These sessions provide early content. Both webinars will be recorded for later viewing as well.Hook 'em!
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Welcome to a premier interprofessional gathering of mental health leaders! We are thrilled to have you join us for a dedicated exploration of advanced psychiatric pharmacotherapy.
This year we are adding FREE addtional BONUS CE webinars. These sessions provide early content. Both webinars will be recorded for later viewing as well.Hook 'em!
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Program Information for In-Person and Live BroadcastWelcome to a premier interprofessional gathering of mental health leaders! We are thrilled to have you join us for a dedicated exploration of advanced psychiatric pharmacotherapy.
This event is a celebration of the complex, vital, and deeply respected work you do across the spectrum of mental health care. Whether you are reconnecting with fellow alumni or engaging with new colleagues from across the medical, nursing, and pharmacy professions, we hope you find this experience professionally revitalizing.
Our goal is to provide you with the "Implementation Advantage"—rigorous, evidence-based insights that you can translate directly into clinical excellence for your patients. Thank you for being part of this community and for your commitment to the science of care.
Hook 'em!
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Review of Conflicts Policy: The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with the speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Mitigation: The University of Texas at Austin College of Pharmacy event planning committees reviewed the relationships and determined there was no connection between presentations and disclosed relationships.
Vineeth John, MD, MBA, is professor and vice chair for education in the Department of Psychiatry and Behavioral Sciences. John is also the Director of the Geriatric Psychiatry Section and is actively involved in various educational initiatives directed towards enhancing domain expertise among psychiatry residents. He received his medical training from Christian Medical College in Vellore, India and completed his residency in general adult psychiatry at Tufts-New England Medical Center and fellowship in geriatric psychiatry at the University of Miami-Jackson Memorial Hospital. In addition, he holds an MBA from the University of Pittsburgh Katz School of Business. John has held positions of academic leadership at the University of Pittsburgh Medical Center, University of Miami Miller School of Medicine, and University of Wisconsin School of Medicine. From 2010-2015, he directed the General Adult Psychiatry Residency Program in the Department of Psychiatry and Behavioral Sciences at McGovern Medical School.
Disclosure: Dr. John does not have any relevant financial relationship(s) with ineligible companies
M. Lynn Crismon is Dean Emeritus and Behrens Centennial Professor Emeritus of Pharmacy and Professor of Psychiatry & Behavioral Sciences at The University of Texas at Austin. He earned a BS in pharmacy from the University of Oklahoma and a Doctor of Pharmacy Degree from a joint program of The University of Texas at Austin and The University of Texas Health Science Center at San Antonio. He completed a PGY-1 residency at the USPHS Gallup Indian Medical Center and a residency in psychiatric pharmacy at The University of Texas and San Antonio State Hospital. He is board certified in psychiatric pharmacy, and he is a Diplomate of the American Board of Clinical Pharmacology. He has over 47 years of experience in mental health care, and his research focused on strategies to improve the pharmacotherapy and health outcomes of adults and children with severe mental disorders. He is the mental health vice chair and a founding steering committee member, faculty member, and coach in the REACH Institute’s Patient-Centered Mental Health in Pediatric Primary Care Mini-fellowship. He is the clinical pharmacy lead for the UT System Health Intelligence Platform contract from the Texas Pharmaceutical Initiative. He has been awarded the ACCP Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy, the ASHP Board of Directors’ Distinguished Service Award, and the AACP Paul R. Dawson Award for Excellence in Patient Care Research.
Disclosure: Dr. Crismon does not have any relevant financial relationship(s) with ineligible companies
That’s a Wrap! Thank You for Joining Us